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Bone a 
for the 
osteosarcorna in 18 dogs 
The results achieved in 18 dogs following the use of frozen bone 
cortical allografts for limbsparing resection of non-metastatic 
canine appendicular osteosarcoma are presented. Three to flve 
cisplatin doses (70 mg/m2) were administered, starting the day 
after surgery. The mean and median survival times were 478 and 
266 days (range 80 to 2611 days), respectively. The survival rate 
was 94 per cent at three months, 78 per cent at six months, 35 per 
cent at 12 months, 23 per cent at 18 months and 19 per cent at 24 
months; the disease-free interval was 80 to 1246 days (mean 365 
days, median 266 days). Lung metastasis developed in 55 per cent 
of the dogs within one year. Complications were observed in 14/18 
dogs (78 per cent), comprising local recurrence (28 per cent), 
allograft infection (39 per cent) and implant failure ( 1 1  per cent). 
Despite complications, limb sparing is a useful alternative to 
amputation in selected cases of appendicular osteosarcoma. 
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INTRODUCTION 
Osteosarcoma (OSA) represents 85 per 
cent of all canine primary bone tumours 
(Jongeward 1985). Its clinicaUbiological 
features have been extensively reviewed 
(Straw and others 1990, O’Brien and oth- 
ers 1993, Ogilvie and Moore 1995). Lung 
metastasis represents the cause of death 
within five to 12 months in approximately 
90 per cent of dogs with OSA treated 
solely by amputation (Brodey and Abt 
1976, Spodnick and others 1992, 
MacEwen and Kurzman 1996), probably 
as a result of micrometastasis already 
present at the time of surgery (Thompson 
and Fugent 1992). 
OSA is both a local and systemic disease 
and improvement in survival can be 
achieved by combining surgery with 
chemotherapy (Berg and others 1992). If 
associated with chemotherapy, the type of 
surgery (amputation versus limb sparing) 
does not influence survival (Straw and 
Withrow 1996). Improved survival has 
been reported following the administra- 
tion of cisplatin (Shapiro and others 1988, 
Kraegel and others 199 1, Straw and others 
1991, 1994, Berg and others 1992, 
Thompson and Fugent 1992), doxoru- 
bicin (Berg and others 1995), cisplatin 
alternated with doxorubicin (Mauldin and 
others 1988), and carboplatin (Bergman 
and others 1996). 
Canine appendicular OSA is com- 
monly treated by amputation. This is a 
well tolerated procedure, usually free of 
complications, and even large dogs can 
function well if no other significant neuro- 
logical and/or orthopaedic disease is pre- 
sent (O’Brien and others 1993, Straw 
1996). Many owners are satisfied with 
the pet’s quality of life after amputation 
(Carberry and Harvey 1987), but some do 
not accept this option. 
When amputation is not permitted, 
limb-sparing surgery offers an alternative 
approach (Wong and others 1986, Vasseur 
1987, LaRue and others 1989, 
Buracco and others 1998, Straw and 
Withrow 1996). The results have been 
considered satisfactory both in terms of the 
animal’s quality of life and survival when 
compared with amputation. Limb sparing 
usually consists of an ‘en bloc’ tumour 
resection and replacement with a fresh- 
frozen cortical bone allograft, fixed to the 
host bone with a dynamic compression 
plate and screws. Arthrodesis of the nearby 
joint is usually required. Although allo- 
grafts cannot contribute living cells for 
osteogenesis, they are able to allow 
osteoinduction in the recipient and to 
provide osteoconduction (Stevenson 1993, 
Newman-Gage 1998). 
The purpose of this paper is to present 
the results achieved with allograft limb 
sparing and cisplatin for the treatment of 
non-metastatic appendicular OSA in 18 
dogs. 
MATERIALS AND METHODS 
Eighteen dogs referred to the Veterinary 
School of Turin between 1991 and 1996 
were included in the study. Criteria for 
inclusion were no clinical or radiological 
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Table 1. Tumour location and case details for the 18 dogs included in the study 
FIG 1. Postoperative radiograph showing 
application of a cortical allograft following 
resection of a dlstal radius osteosarcoma 
(case 15) 
evidence of metastasis at presentation and 
a histologically confirmed diagnosis of 
appendicular OSA, not involving more 
than 50 per cent of the diaphysis. The 
work-up included history, physical exami- 
nation, complete blood count, serum 
biochemical analysis and urinalysis. Radio- 
graphic evaluation of the limb (lateral and 
craniocaudal views) and chest (right and 
left lateral, and dorsoventral views at inspi- 
ration) was performed to examine tumour 
features and extension, and to look for evi- 
dence of pulmonary metastasis. Enlarged 
regional lymph nodes were aspirated and 
smears examined cytologically. A biopsy 
of the bone lesion was obtained using 
a Jamshidi needle and submitted for 
histopathology. 
A bank of fresh-frozen cortical bone 
allograft was established. Bones were har- 
vested (with the owners’ permission) from 
animals which had died from trauma and 
had been assessed to be free from infec- 
tious or neoplastic disease. Donors were 
young to middle-aged large-breed dogs of 
both sexes. Bones were removed using a 
standard aseptic surgical procedure. They 
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periosteum, and the bone marrow was 
removed by flushing the intramedullary 
canal with sterile saline. Samples for aero- 
bic and anaerobic culture were taken from 
the grafts after preparation. Bones were 
doubled wrapped in sterile plastic bags, 
identified and stored in a household freezer 
at -20°C for a maximum of one year. 
Before use, allografts were thawed in 
10 per cent povidone-iodine solution in 
sterile normal saline, washed with sterile 
normal saline and resampled for culture as 
above. 
Care was taken to prepare the host limb 
aseptically to limit bacterial contamination 
during surgery. Antibiotics (cephazolin 
22 mg/kg [Cephamezin; Pharmacia & 
Upjohn]) were administered intravenously 
at induction of anaesthesia and every two 
hours during surgery. Soft tissues were dis- 
sected around the tumour, so that most 
neurovascular structures were present. 
The first osteotomy was created with an 
oscillating bone saw approximately 3 to 
4 cm beyond the diaphyseal radiographic 
margin of the tumour to maximise the 
likelihood of tumour-free margins. The 
cut was made perpendicular to the long 
axis of the bone to achieve the correct 
alignment of the allograft with maximal 
cortical contact. Where there was sec- 
ondary radiographic and/or macroscopic 
extension of OSA of the radius to the ulna, 
the latter was cut together with the radius. 
The tumour was excised, avoiding gross 
penetration of the tumour, after disarticu- 
lation of the adjacent joint. At this time 
the diaphyseal host stump bone marrow 
and the surrounding tissues were cytologi- 
cally evaluated for neoplastic cells. 
The joint was prepared for arthrodesis 
by thoroughly removing all the articular 
cartilage followed by flushing with sterile 
normal saline. The defect was filled with 
the defrosted cortical bone allograft, mod- 
elled to fit the defect and to give maximal 
contact between graft/host interfaces. The 
allograft was stabilised using a dynamic 
compression plate fixed with screws based 
on the ASIF/AO technique (Perren 1998) 
(Fig 1). Autogenous cancellous bone, 
harvested from the ilial wing, was used 
when the hodgraft interface contact was 
not perfect. 
Postoperatively, the surgical site was 
protected with a modified Robert Jones 
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Table 2. Clinical history and the results of treatment for the 18 dogs included in the study 
Case Infection Recurrence Metastases Status Disease-free Survival time Limb Comments 
interval (days) (days) functlon 
1 None Y Y Dead 80 80 Good 
2 Serious N N Dead 129 129 Poor Allograft infection: euthanasia 
3 None N Y Dead 140 140 Excellent 
4 Mild Y Y Dead 147 147 Good 
5 None N N Dead* 180 180 Good Implant failure due presumably 
to the excessive length of the 
allograft: amputation after 
26 days. 
*Gastric dilatation-volvulus 
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Amputation refused by the owner 
Implant failure: plate replaced 
Recurrence: amputation after Myelosuppression 
396 days 
*Anal sac adenocarcinoma 
*Poisoning by pesticides 
*Hit by car Renal parameters 
Recurrence: amputation after 
582 days 
increased 
‘Death due to tumour-unrelated causes 
Y Yes. N No 
bandage for seven to 10 days, and anti- 
biotics (cephazolin 22 mg/kg twice daily) 
were administered for seven to 10 days. 
Activity was restricted to walking on the 
lead during the first month. 
Adjuvant chemotherapy with cisplatin 
(Platamine; Pharmacia & Upjohn) was 
administered intravenously at a dosage of 
70 mg/m2 in the middle of a six-hour 
hydration period (rate: 17 ml/kg/hour of 
saline) every three weeks for three to five 
treatments, starting the day after surgery. 
Owing to its potential side effects, periph- 
eral blood cell counts and renal parameters 
were monitored before each drug adminis- 
tration and after 15 days. Metoclopramide 
(0.2 to 0.4 mg/kg [Plasil; Lepetit]) was 
given where nausea and vomiting devel- 
oped. 
All the excised tumours were submitted 
for histopathological examination to 
confirm the biopsy diagnosis. 
Dogs were reassessed at the Veterinary 
School of Turin for metastasis, limb func- 
tion, allograft infection, implant failure, 
local recurrence and allograft healing on a 
monthly basis for the first three months 
and every three months thereafter. Limb 
function was evaluated according to a 
grading system: excellent (slight or no 
lameness), good (mild lameness), fair (evi- 
dent lameness) and poor (severe lameness 
or no use of the limb) function at walk 
(Peirone and others 1994). The degree of 
local infection was graded as serious 
(radiographic evidence of infection of the 
entire allograft with marked limb swelling, 
fistulas and no use of the limb), mild 
(radiographic evidence of localised areas of 
infection, intermittent fistulas and lame- 
ness), and slight (infection of superficial 
soft tissue, no fistulas, no radiographic 
evidence of bone involvement and normal 
limb function). 
The survival time referred to in this 
study corresponds to the interval between 
surgery and radiographic evidence of 
lung metastasis and/or any cause of 
death. In fact, when lung metastasis was 
detected, no further curative treatment 
was undertaken and most of these dogs 
were lost to follow-up. The disease-free 
period was considered to be the interval 
between surgery and radiographic evi- 
dence of lung metastasis and/or local 
recurrence. 
RESULTS 
Fourteen male and four female dogs were 
included in the study (Table 1). The 
median age was seven years (range two to 
12 years). All dogs were purebred animals 
of more than 25 kg bodyweight, with the 
exception of one crossbred dog, which 
weighed 13 kg. This dog had radiographic 
signs compatible with bone infarctions, 
and a possible preneoplastic lesion 
(Dubielzig and others 1981, Prior and 
others 1986, Waters and Cooley 1998) in 
several appendicular bones. The distal radius 
was the most common site of OSA (1 1); 
other tumour locations were the distal tibia 
(2), proximal humerus (I) ,  proximal tibia 
( I ) ,  distal femur ( I ) ,  proximal radius (1) 
and distal ulna (1). None of these dogs had 
detectable lymphatic metastasis at presen- 
tation or developed it later. All OSAs were 
staged T2NOMO at presentation (Owen 
1980). 
The mean and median survival times 
were 478 and 266 days, respectively (range 
80 to 261 1 days). The survival rate was 
94 per cent (17/18 dogs) at three months 
after surgery, 78 per cent (1 4/ 18 dogs) at 
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Site of arthrodesis 
Carpus Stifle 
(ll cases) (two cases) 
Limited Evident 
loss of circumduction 
function of the limb at 
walking 
None or Severe 
slight 
None Mlld to severe 
depending on 
the size of dog 
six months, 35 per cent (6/17 dogs; one 
was excluded because of tumour-unrelated 
death) at 12 months, 23 per cent (4117 
dogs) at 18 months and 19 per cent (3/16 
dogs; one more dog was excluded because 
of tumour-unrelated death) at 24 months. 
Radiographic evidence of lung meta- 
stasis (Table 2) was detected in 55 per cent 
of the dogs (10 cases), 80 to 369 days after 
surgery. One dog had radiographic evi- 
dence of metastasis within three months 
(5 per cent), two within six months (1 1 per 
cent) and seven within one year (39 per 
cent). Four dogs (22 per cent) died for 
reasons unrelated to both OSA and its 
treatment (Table 2). 
The complications (Table 2) that 
occurred were: local recurrence, allograft 
infection and implant failure. Five dogs 
had local recurrence (28 per cent; three in 
the distal radius, one in the proximal 
radius and one in the distal ulna) 80 to 582 
days after surgery. Three out of five recur- 
rences were observed where OSA originally 
involved only the radius or ulna and the 
other bone was not removed; in the other 
two cases (distal radius OSA), the ulna was 
removed. Two of these five dogs underwent 
amputation but one died during surgery, 
while the second was still alive at the time 
of writing. Of the remaining three cases, 
two were euthanased because of 
concomitant evidence of lung metastasis 









FIG 2. Case 1 0 , l O  months after surgery. 
Allograft appears well incorporated and a 
radlodense pattern Is prevalent 
further treatment in the fifth case, and this 
dog underwent euthanasia after a few days. 
Seven dogs (39 per cent) had local 
infection. This was serious in one dog, and 
the case was euthanased because the owner 
refused amputation; in the other six dogs, 
infection was mild to slight and was con- 
trolled within 15 to 30 days of antibiotic 
administration, according to microbiologi- 
cal and sensitivity tests. Case 4 had both 
mild infection and local recurrence. 
Implant failure occurred in two dogs 
(1 1 per cent). In the first (distal tibial allo- 
graft), the broken plate was replaced; in the 
second dog (distal radial allograft), ampu- 
tation was undertaken (owner’s decision). 
All dogs received at least three adjuvant 
doses of cisplatin that were usually well tol- 
erated. At the most, nausea and vomiting 
were observed during the following two to 
three days; in these cases metoclopramide 
was useful in diminishing the intensity of 
these side effects. In four dogs, the neu- 
trophil count dropped below 3 x 1 03/ml; 
in these cases, a cephalosporin was given 
and the cisplatin administration was 
delayed until the neutrophil count 
exceeded 3 x 103/ml. A slight and tran- 
sient increase in blood urea nitrogen and 
creatinine values was recorded in two dogs. 
Limb function was good to excellent in 
72 per cent of the dogs. Most dogs were 
able to use the leg within one month of 
surgery. Limb function was good to excel- 
lent for carpal arthrodesis, fair for tarsal 
(medial plate) arthrodesis and poor for 
shoulder and stifle arthrodesis, the last 
depending on the size of the dog. In fact, 
dog 6 had a hindlimb amputation because 
it was unable both to rise or walk (Table 3). 
Limb radiographs taken during the 
follow-up period showed an initial bone 
healing in the form of a periosteal bridging 
across interfaces four to eight weeks after 
surgery that usually stopped progressing at 
24 weeks. Radiographic union was consid- 
ered complete when cortical continuity 
was evident across the graft-host interface 
and periosteal and endosteal callus under- 
went active remodelling (within one year) 
(Fig 2). None of the dogs had the plate 
removed. 
DISCUSSION 
Amputation is the elective option in most 
cases of appendicular OSA and is usually 
free of complications. In the present study, 
all dogs’ owners were first encouraged 
toward this procedure, but when it was 
rejected or when orthopaedic or neurologi- 
cal reasons precluded amputation, limb 
sparing was considered. Unlike amputa- 
tion, limb sparing is a costly and technically 
demanding procedure that requires a dedi- 
cated owner and a docile animal. Compli- 
cations may arise and the owner must be 
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fully aware of these before proceeding. 
Despite these aspects, results are often 
gratifying when cases are carefully selected. 
Patients in the study were able to 
weightbear within a few days of surgery. 
Limb function depends mostly on the 
joint involved in the arthrodesis (Table 3). 
In the authors’ experience, the ideal candi- 
dates are dogs with distal radius OSA, 
owing to the limited loss of function after 
carpal arthrodesis. 
In the case of the proximal radius OSA 
(case 18), a very atypical location, 
the resection of only the radius resulted 
in good function despite the fact that a 
cortical allograft without articular cartilage 
was used and elbow arthrosis developed 
subsequently. 
Poor limb function was observed in this 
and other studies (LaRue and others 1989, 
Kuntz and others 1998) where shoulder 
and stifle arthrodesis (cases 2, 6) was per- 
formed, although small dogs can tolerate 
this procedure (case 17). 
Hock arthrodesis, achieved using a 
medial plate, resulted in fair function. 
Better results could have been achieved 
with a dorsal plate positioning (McKee 
1994). An increased complication rate 
due to the poor soft tissue coverage over 
the allograft/plate system has been 
reported following surgery at this site 
(Straw 1996). 
Suitable candidates for limb sparing are 
dogs with OSA not involving more than 
50 per cent of the length of the diaphysis, 
since a stable host allograft system cannot 
be achieved if the allograft is too long and 
only a few screws (less than four) can be 
inserted in the host bone after OSA 
removal (Table 2, case 5) (Straw and 
Withrow 1996). 
Recurrence was an important local 
complication in this series. It never 
occurred at the allograft/host interface, 
confirming a complete excision after dia- 
physeal osteotomy and joint disarticula- 
tion. In the author’s opinion, the 
evaluation of recent radiographs, together 
with intraoperative cytological examina- 
tion of the host stump bone marrow 
smears, represents a reliable method for 
assessing a free-margin osteotomy. It is pre- 
sumed that recurrences develop from the 
undetected extension of the tumour in the 
surrounding soft tissue and the micro- 
scopic involvement of the adjacent bone. 
Removal of the paired bone (ulna or 
radius in the case of distal radius or ulna 
OSA, respectively) is controversial. Even 
though its persistence provides stability to 
the implant system, its removal could pre- 
vent a local recurrence arising from the 
microscopic involvement of the adjacent 
bone, although no conclusion on this pos- 
sibility can be drawn from the present 
series. At the time ofwriting, no procedure, 
including cytological analysis, has proved 
to be h l ly  reliable in detecting microscopic 
neoplastic involvement of surrounding tis- 
sues during surgery. Indeed, even though 
the cytological analysis was always negative 
in the present study, recurrences occurred. 
A reduction of local recurrences (from 27 
to 17 per cent) has been obtained through 
a slow release of cisplatin within the surgi- 
cal wound (Straw and others 1994). 
Other complications encountered in 
the present study were infection and 
implant failure. Infection has been attrib- 
uted to extensive surgical resection and 
damage to the vascular supply, lengthy 
procedure duration, implantation of 
metallic devices in non-vascularised bone, 
limited soft tissue coverage, chemotherapy, 
undetected foci of infection somewhere in 
the body and licking (Straw and Withrow 
1996). Measures to prevent infection 
include aseptic surgical technique, 
appropriate peri- and intraoperative 
administration of intravenous antibiotics, 
and prevention of licking and any other 
postsurgical trauma. 
Different degrees of infection were seen. 
Recurrent wound drainage was the most 
frequent form and this was adequately 
controlled with systemic antibiotics and 
basic wound management. Only in one 
dog was this type of infection serious 
enough to require amputation. 
Infection was frustrating but, when 
slight to mild, it was only associated with 
an intermittent mild decrease in limb 
function. In more severe infections, the 
local implantation of aminoglycoside- 
impregnated polyrnethylmethacrylate beads 
has been reported to be of value (Dernell 
and others 1998). 
Interestingly, it has been noted (Straw 
1996) that dogs which develop infection 
have a longer survival than those that do 
not, perhaps due to an increased immune- 
system stimulation. The use of antibiotic- 
impregnated polymethylmethacrylate 
cement placed within the medullary canal 
should help to decrease the infection rate 
(O’Brien and others 1993); the bone 
cement should also limit screw loosening, 
which can occur during allograft revascu- 
larisation and resorption (Straw and 
Withrow 1996). 
Cisplatin was used as an adjuvant 
treatment in the present study. Emesis, a 
common sign following cisplatin adminis- 
tration, depends mostly on the dose of 
the drug used (Ogilvie and others 1989). It 
has been reported that vomiting can be 
prevented by not administering the drug 
pretreatment; metoclopramide was used 
only to decrease vomiting when this devel- 
oped in the present study. 
Cisplatin was chosen on the basis of 
previous reports about its eficacy against 
OSA when combined with surgery 
(Berg and others 1992, Thompson and 
Fugent 1992). The authors’ results, in 
terms of median survival, appear similar to 
those reported by LaRue and others 
(1989). This finding confirms that, when 
cisplatin was given, dogs managed by limb 
sparing had no significant difference in 
survival compared with those whose limbs 
were amputated and which had received 
similar chemotherapy (Shapiro and others 
1988, Straw and others 1991). The high 
metastatic rate, despite chemotherapy, 
reported in this and other studies, repre- 
sents the major challenge in the manage- 
ment of OSA. More efforts are needed 
to find new strategies to limit metastasis. 
In the present series, the likelihood of 
development of lung metastasis was higher 
during the first year postsurgery. 
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A significant problem encountered in 
the present study was the availability of 
allografts, mostly in terms of maintenance 
of a bank because of both the difficulty of 
finding appropriate donors and legal 
restrictions. New approaches to limb 
sparing have been described, such as the 
reimplantation of the excised tumour fol- 
lowing pasteurisation (Buracco and others 
1998) or application of the Ilizarov appara- 
tus (Tommasini Degna and others 2000). 
Conclusions 
Results obtained from this series are similar 
to those reported in the literature regard- 
ing survival, limb function and complica- 
tions. Limb sparing is an alternative to 
amputation in selected cases of appendicu- 
lar OSA. Although the dogs' owners were 
not asked to fill in a form on the quality of 
life of their pet following limb-sparing 
surgery, their comments were positive, 
despite the high complication rate related 
to the technique. This would be in agree- 
ment with the oncologist's goals: to treat 
cancer while assuring a good quality of life 
in terms of both pain relief and limb hnc-  
tion. Complete resection of the tumour is 
essential for local control and, at the time 
of writing, adjuvant chemotherapy is the 
only treatment that addresses metastatic 
disease and improves overall survival in 
such cases of OSA. 
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